Clindamycin Capsules I.P.300 MG.

₹ 3,170/Box

Strength300 mg
Quantity UnitBox
Country of OriginMade in India
AvailabilityIn Stock
View in Hindi क्लिंडामाइसिन कैप्सूल I.P.300 MG.
Clindamax 300mg Capsule is a versatile antibiotic medicine that works by stopping the growth of bacteria in your body. This medicine is used to treat many different types of infections such as those of lungs (pneumonia), stomach, skin & soft tissues, bones & joints, blood, and heart.

Find products similar to Clindamycin Capsules I.P.300 MG.

Find related categories

Shipping Information

PriceExcluding all taxes
Ships fromPanchkula
ShippingAs per delivery location

Product Image

Clindamycin Capsules I.P.300 MG. image 1Clindamycin Capsules I.P.300 MG. image 2Clindamycin Capsules I.P.300 MG. image 3Clindamycin Capsules I.P.300 MG. image 4Clindamycin Capsules I.P.300 MG. image 5Clindamycin Capsules I.P.300 MG. image 6Clindamycin Capsules I.P.300 MG. image 7Clindamycin Capsules I.P.300 MG. image 8Clindamycin Capsules I.P.300 MG. image 9Clindamycin Capsules I.P.300 MG. image 10Clindamycin Capsules I.P.300 MG. image 11

About the Company

GST Registration Date
Apr 2022
Legal Status of Firm
Limited Company
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
Upto 10 People
Annual Turnover
1.5 - 5 Cr
IndiaMART Member Since
Aug 2017
GST
06**********1ZT

Established in the year of 2020. We “Derma 360 Private Limited” are a leading Manufacturer, Wholesale Distributor, Trader And Supplier of a wide range of

Derma Company Franchisee, Pharmaceutical Tablets,Allopathic Pcd Pharma Franchise etc.

We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.

For our accomplishment story, we are grateful to Our CEO Mr. Manuj Doomra  whose continual backing and direction have been useful to us for attaining exponential development in the current market